» Articles » PMID: 23324111

Need for Insulin to Control Gestational Diabetes is Reflected in the Ambulatory Arterial Stiffness Index

Overview
Publisher Biomed Central
Date 2013 Jan 18
PMID 23324111
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim was to evaluate the metabolic profile in conjunction with vascular function using the ambulatory arterial stiffness index (AASI) in women with uncomplicated pregnancies and in women with gestational diabetes mellitus (GDM).

Methods: Plasma glucose, lipids, HOMA -IR (homeostasis model assessment of insulin resistance) and AASI, as obtained from 24-hour ambulatory blood pressure monitoring in third trimester pregnancy and at three months postpartum, were measured in three groups of women: controls (N=32), women with GDM on diet (N=42) and women with GDM requiring insulin treatment (N=10).

Results: Women with GDM had poorer glycemic control and higher HOMA-IR during and after pregnancy and their total and LDL (low density lipoprotein) cholesterol levels were significantly higher after pregnancy than in the controls. After delivery, there was an improvement in AASI from 0.26±0.10 to 0.17±0.09 (P=0.002) in women with GDM on diet, but not in women with GDM receiving insulin whose AASI tended to worsen after delivery from 0.30±0.23 to 0.33±0.09 (NS), then being significantly higher than in the other groups (P=0.001-0.047).

Conclusions: Women with GDM had more unfavorable lipid profile and higher blood glucose values at three months after delivery, the metabolic profile being worst in women requiring insulin. Interestingly, the metabolic disturbances at three months postpartum were accompanied by a tendency towards arterial stiffness to increase in women requiring insulin.

Citing Articles

Differences in lipid metabolism in acquired versus preexisting glucose intolerance during gestation: role of free fatty acids and sphingosine-1-phosphate.

Liebmann M, Grupe K, Asuaje Pfeifer M, Rustenbeck I, Scherneck S Lipids Health Dis. 2022; 21(1):99.

PMID: 36209101 PMC: 9547403. DOI: 10.1186/s12944-022-01706-x.


Gestational Diabetes Mellitus Treatment Schemes Modify Maternal Plasma Cholesterol Levels Dependent to Women´s Weight: Possible Impact on Feto-Placental Vascular Function.

Contreras-Duarte S, Carvajal L, Garchitorena M, Subiabre M, Fuenzalida B, Cantin C Nutrients. 2020; 12(2).

PMID: 32079298 PMC: 7071311. DOI: 10.3390/nu12020506.


Pregnancy-related events associated with subclinical cardiovascular disease burden in late midlife: SWAN.

Cortes Y, Catov J, Brooks M, El Khoudary S, Thurston R, Matthews K Atherosclerosis. 2019; 289:27-35.

PMID: 31446211 PMC: 6952268. DOI: 10.1016/j.atherosclerosis.2019.07.012.


Lipid Fingerprinting in Mild versus Severe Forms of Gestational Diabetes Mellitus.

Gueuvoghlanian-Silva B, Cordeiro F, Lobo T, Cataldi T, Lo Turco E, Bertolla R PLoS One. 2015; 10(12):e0144027.

PMID: 26633694 PMC: 4669127. DOI: 10.1371/journal.pone.0144027.

References
1.
Ingelsson E, Bjorklund-Bodegard K, Lind L, Arnlov J, Sundstrom J . Diurnal blood pressure pattern and risk of congestive heart failure. JAMA. 2006; 295(24):2859-66. DOI: 10.1001/jama.295.24.2859. View

2.
Krishnaveni G, Hill J, Veena S, Geetha S, Jayakumar M, Karat C . Gestational diabetes and the incidence of diabetes in the 5 years following the index pregnancy in South Indian women. Diabetes Res Clin Pract. 2007; 78(3):398-404. PMC: 2358951. DOI: 10.1016/j.diabres.2007.06.002. View

3.
Qvigstad E, Voldner N, Godang K, Henriksen T, Bollerslev J . Overweight is associated with impaired beta-cell function during pregnancy: a longitudinal study of 553 normal pregnancies. Eur J Endocrinol. 2009; 162(1):67-73. DOI: 10.1530/EJE-09-0416. View

4.
Savvidou M, Anderson J, Kaihura C, Nicolaides K . Maternal arterial stiffness in pregnancies complicated by gestational and type 2 diabetes mellitus. Am J Obstet Gynecol. 2010; 203(3):274.e1-7. DOI: 10.1016/j.ajog.2010.06.021. View

5.
Schillaci G, Parati G . Ambulatory arterial stiffness index: merits and limitations of a simple surrogate measure of arterial compliance. J Hypertens. 2008; 26(2):182-5. DOI: 10.1097/HJH.0b013e3282f52fb9. View